Pat Heckman, DO @IndyOncDoc X Profile

Pat Heckman, DO

@IndyOncDoc

Followers

32

Following

17

Media

4

Statuses

9

PGY-5 Heme/Onc Fellow @UKMarkey

Joined December 2022

Don't wanna be here? Send us removal request.

Pat Heckman, DO

@IndyOncDoc

1 year

RT @UKMarkey: Congratulations to our graduating @UKHemOnc.fellows! We are excited that @chahine_zena will continue in Hematology @UKMarkey.….

0

2

0

Pat Heckman, DO

@IndyOncDoc

2 years

RT @UKHemOnc: Hail the new chiefs! @MCCTrainees @UKMarkey @Reema_PatelMD @aejohn02 @IndyOncDoc @HemOncFellows @universityofky @ReshmaRamlal….

0

4

0

Pat Heckman, DO

@IndyOncDoc

2 years

RT @UKHemOnc: Fellowship life is busy and we don’t always have time for fun. When we do we do it only with Joe’s original Kansas City barbe….

0

6

0

Pat Heckman, DO

@IndyOncDoc

2 years

Curious how these results would affect our our abstract “Oncologists’ Perspectives on mHSPC Management” #GU23

1

3

Pat Heckman, DO

@IndyOncDoc

2 years

Updated #ARASENS results show OS benefit w/ triplet therapy (ADT + Docetaxel x6C + Darolutamide) regardless of volume/risk stratification. *Large % are de novo #GU23

1

4

Pat Heckman, DO

@IndyOncDoc

2 years

Starting off the morning at #GU23 with PARPi in mCRPC

0

1

4

Pat Heckman, DO

@IndyOncDoc

2 years

Enjoyed listening to @neerajaiims, @TDorffOnc, and @DrRanaMcKay discuss the (near) future in prostate cancer management. As a trainee, the abundance of therapies can be intimidating but that pales in comparison to the invigorating hope I have for our patients! #GU23.

0

5

Pat Heckman, DO

@IndyOncDoc

3 years

@BaraAlzghoulMd @chahine_zena @aejohn02.

0

Pat Heckman, DO

@IndyOncDoc

3 years

Journal club today! Talking adagrasib + cetuximab in KRAS G12C mutated mCRC - ORR 46% / mPFS 6.9mo … not a silver bullet but maybe the start of meaningful targeted responses in mCRC - esp. for an “undruggable” & prevalent mutation

1

3